Alfresa Holdings Corp, founded in 1949 and headquartered in Tokyo, Japan, is a leading pharmaceutical and healthcare company dedicated to enhancing the quality of life through innovative medical solutions. The company specializes in the distribution of pharmaceuticals, healthcare products, and other related services, catering to a diverse range of healthcare needs across Japan.
| Bond Name | Country | Maturity | Coupon(%) | |||
|---|---|---|---|---|---|---|
| No data found! | ||||||
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Alfresa first entered the bond market in the early 2000s, demonstrating its commitment to financial stability and growth. Notable issuances include a ¥10 billion bond in 2014, aimed at financing strategic acquisitions, which notably featured a 10-year maturity with competitive yields compared to industry benchmarks. As of October 2023, Alfresa’s bonds are yielding around 0.8%, reflecting a stable position in the marketplace amidst fluctuating interest rates. Recent news indicates plans for further bond issuances to support ongoing expansion efforts, signaling investor confidence in the company’s long-term objectives.